Bringing Tomorrow’s Technology to Today’s Patients
“Carolina Eyecare Research Institute is one of the lowcountry’s largest privately-held ophthalmology research centers. From investigating better surgical techniques and therapeutic treatments, to testing new medical devices, our state-of-the-art research center is focused on testing and improving new technologies and procedures for cataract surgery, refractive lens surgery, LASIK vision correction, and improving treatment for glaucoma, macular degeneration and diabetic retinopathy.”
-The Physicians at Carolina Eyecare
“The Carolina Eyecare Research Institute is committed to advancing the field of ophthalmology with progressive, groundbreaking studies that improve not only our patients quality of life from Charleston and around the low country, but also those around the world. Our goal is to bring tomorrow’s technology to today’s patients.”
-Dr. Kerry Solomon, Director; Carolina Eyecare Research Institute
About the Director
Dr. Kerry D. Solomon is the first Director of the Carolina Eyecare Research Institute at Carolina Eyecare Physicians in Charleston, SC. He has been a leader, an innovator and a pioneer with cataract and refractive surgery and clinical research for more than 20 years. He was the first recipient of the Arturo and Holly Melosi Professor of Ophthalmology Chair and was a physician at the Medical University of South Carolina (MUSC) for 17 years. Dr. Solomon held key positions at MUSC, including Director of the cataract, refractive and cornea services at Storm Eye Institute, Medical Director of the Magill Vision Center and Director of the Magill Research Center.
Dr. Solomon completed his internship at Yale University in New Haven, CT, and his residency at the University of Kentucky in Lexington, KY. He completed his fellowship at Johns Hopkins Hospital in Baltimore, MD, specializing in cataract and refractive surgery and corneal transplantation. He also completed a fellowship in ophthalmic pathology at the University Of Utah Health Sciences Center. Dr. Solomon was recruited to Storm Eye Institute upon completion of his training at Johns Hopkins. A board-certified member of the American Board of Ophthalmology, Dr. Solomon is a member of many national and international professional and scientific societies often serving in leadership roles. He is currently Chair of the Food and Drug Administration liaison committee for the American Society of Cataract and Refractive Surgery (ASCRS), the largest surgical society for eye surgeons in the world. Additionally, Dr. Solomon has authored more than 170 publications and has received numerous awards including receiving the “Best Doctors” award every year since 2002. Since its inception in 2005, he has been voted by his peers as being one of the top 50 opinion leaders around the world for cataract and refractive surgery, and he was the second recipient of the Lee Nordan Refractive Surgeon of the Year Award.
Dr. Solomon is sought after worldwide for his teaching and surgical skills. He frequently presents lectures to peers, having presented more than 500 lectures and live surgical demonstrations. Most recently, Dr. Solomon was the United States representative and invited guest for the Russian Cataract and Refractive Surgery Society in Moscow.
Carolina Eyecare Physicians’ Answers to Frequently Asked Questions
Symfony Toric Intraocular Lens Visual Outcomes
In July 2016, the FDA approved an extended depth of focus (EDOF) IOL (Tecnis Symfony, Abbott Medical Optics) helping to improve the sharpness of vision at near, intermediate and far distances reducing the need of glasses after cataract surgery. It is available in both a non-toric version and a toric version for patients with astigmatism. The difference between this lens and the multifocal (MIOL) counterpart is that the EDOF, similarly to a monofocal IOL, has one focal point (elongated in the EDOF) while the multifocals have 2 focal points; therefore, having less of a halo and glare problem. Pivotal trial results where Symfony was compared to a monofocal IOL showed similar uncorrected distance visual acuity (UCDVA), better intermediate (77% vs. 34% 20/25 uncorrected intermediate visual acuity – UCIVA) and near vision (Symfony patients were able to read two additional, progressively smaller lines compared to the monofocal IOL).A One potential disadvantage of the EDOF IOL compared to a MIOL is the visual performance at near.B One option to deal with this potential shortcoming is to set the non-dominant eye for a small residual myopic error (-0.50 D)C what is referred to as nano-vision or mini mono-vision.
Optimizing the Assessment of Refractive Outcomes After Cataract Surgery
The purpose of this study is to evaluate currently available assessments (automated vs. manual) with which manifest refraction data and biometric variables are obtained to understand if data from an automated refractor can be utilized to optimize the A-constant as well as manual subjective refraction (ie, to a clinically insignificant difference). The A-constant is the calculated number that helps the surgeon determine which IOL should be implanted in the eye during cataract surgery.
Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens
The purpose of this study is to evaluate the safety and performance of the SBL-3 intraocular lens.
Compensation is available for qualifying patients. Enrollment is limited. Medicare & most insurance accepted.
Call (843)-881-3937 to find out if you may qualify!